Alpha 2.0
Login Register
» Articles » PMID: 4813955

Effects of Glucagon on Plasma Lipids in Different Types of Primary Hyperlipoproteinemia

Overview
Journal Metabolism
Specialty Endocrinology
Date 1974 Mar 1
PMID 4813955
Citations 11
Authors
F Aubry
Y L Marcel
J Davignon
Affiliations
Soon will be listed here.
Citing Articles

Impaired Fat Absorption from Intestinal Tract in High-Fat Diet Fed Male Mice Deficient in Proglucagon-Derived Peptides.

Nishida K, Ueno S, Seino Y, Hidaka S, Murao N, Asano Y Nutrients. 2024; 16(14).

PMID: 39064713 PMC: 11280123. DOI: 10.3390/nu16142270.

Glucagon resistance and metabolic-associated steatotic liver disease: a review of the evidence.

McGlone E, Bloom S, Tan T J Endocrinol. 2024; 261(3).

PMID: 38579751 PMC: 11067060. DOI: 10.1530/JOE-23-0365.

The Vicious Circle of Hepatic Glucagon Resistance in Non-Alcoholic Fatty Liver Disease.

Galsgaard K J Clin Med. 2020; 9(12).

PMID: 33333850 PMC: 7765287. DOI: 10.3390/jcm9124049.

Glucagon receptor antagonism induces increased cholesterol absorption.

Guan H, Yang X, Lu K, Wang S, Castro-Perez J, Previs S J Lipid Res. 2015; 56(11):2183-95.

PMID: 26373568 PMC: 4617405. DOI: 10.1194/jlr.M060897.

Effects of small interfering RNA-mediated hepatic glucagon receptor inhibition on lipid metabolism in db/db mice.

Han S, Akiyama T, Previs S, Herath K, Roddy T, Jensen K J Lipid Res. 2013; 54(10):2615-22.

PMID: 23828778 PMC: 3770075. DOI: 10.1194/jlr.M035592.